He Y - Search Results

1

Pan-cancer Analysis of Tumor Mutational Burden and Homologous Recombination DNA Damage Repair Using Targeted Next-Generation Sequencing.

Wang HY, Deng L, Li YQ, Zhang X, Long YK, Zhang X, Feng YF, He Y, Tang T, Yang XH, Wang F. Wang HY, et al. Among authors: he y. Cancer Res Treat. 2021 Oct;53(4):973-982. doi: 10.4143/crt.2020.798. Epub 2021 Feb 18. Cancer Res Treat. 2021. PMID: 33677848 Free PMC article.

2

Hypermethylation of APC2 Is a Predictive Epigenetic Biomarker for Chinese Colorectal Cancer.

He Y, Sun LY, Wang J, Gong R, Shao Q, Zhang ZC, Ye ZL, Wang HY, Xu RH, Shao JY. He Y, et al. Dis Markers. 2018 Oct 29;2018:8619462. doi: 10.1155/2018/8619462. eCollection 2018. Dis Markers. 2018. PMID: 30510602 Free PMC article.

3

Interfering Expression of Chimeric Transcript SEPT7P2-PSPH Promotes Cell Proliferation in Patients with Nasopharyngeal Carcinoma.

Wang J, Xie GF, He Y, Deng L, Long YK, Yang XH, Ma JJ, Gong R, Cen WJ, Ye ZL, Zeng YX, Wang HY, Shao JY. Wang J, et al. Among authors: he y. J Oncol. 2019 Apr 1;2019:1654724. doi: 10.1155/2019/1654724. eCollection 2019. J Oncol. 2019. PMID: 31057610 Free PMC article.

4

Mutation spectrum of germline cancer susceptibility genes among unselected Chinese colorectal cancer patients.

Gong R, He Y, Liu XY, Wang HY, Sun LY, Yang XH, Li B, Cao XK, Ye ZL, Kong LH, Zhang DD, Li YH, Xu RH, Shao JY. Gong R, et al. Among authors: he y. Cancer Manag Res. 2019 Apr 29;11:3721-3739. doi: 10.2147/CMAR.S193985. eCollection 2019. Cancer Manag Res. 2019. PMID: 31118792 Free PMC article.

5

Prognostic Implications of Tripartite Motif Containing 24 Expression Levels in Patients with Solid Tumors: A Systematic Review and Meta-Analysis.

He Y, Peng KW, Tang T, Deng L, Ye ZL, Luo MJ, Sun LY, You CX, Shao JY. He Y, et al. Genet Test Mol Biomarkers. 2019 Jul;23(7):473-479. doi: 10.1089/gtmb.2018.0286. Epub 2019 Jun 18. Genet Test Mol Biomarkers. 2019. PMID: 31211611

6

The Percentage of Anaplastic Lymphoma Kinase-Positive Tumor Cells Has Clinical Implications for Patients with Non-Small Cell Lung Cancer.

He Y, Gong R, Sun LY, Zhang ZC, Liu XY, Shao Q, Xu F, Wang HY, Shao JY. He Y, et al. Genet Test Mol Biomarkers. 2019 Aug;23(8):589-597. doi: 10.1089/gtmb.2019.0038. Genet Test Mol Biomarkers. 2019. PMID: 31373849

7

The prevalence of EML4-ALK variants in patients with non-small-cell lung cancer: a systematic review and meta-analysis.

He Y, Sun LY, Gong R, Liu Q, Long YK, Liu F, Wang F. He Y, et al. Biomark Med. 2019 Aug;13(12):1035-1044. doi: 10.2217/bmm-2018-0277. Epub 2019 Aug 21. Biomark Med. 2019. PMID: 31432686

8

Sleep quality, anxiety and depression in advanced lung cancer: patients and caregivers.

He Y, Sun LY, Peng KW, Luo MJ, Deng L, Tang T, You CX. He Y, et al. BMJ Support Palliat Care. 2022 Jul;12(e2):e194-e200. doi: 10.1136/bmjspcare-2018-001684. Epub 2020 Apr 6. BMJ Support Palliat Care. 2022. PMID: 32253349

9

NK homeobox 2.2 functions as tumor suppressor in colorectal cancer due to DNA methylation.

He Y, Liu XY, Gong R, Peng KW, Liu RB, Wang F. He Y, et al. J Cancer. 2020 Jun 6;11(16):4791-4800. doi: 10.7150/jca.43665. eCollection 2020. J Cancer. 2020. PMID: 32626526 Free PMC article.

10

Lymphocyte-to-C-reactive protein ratio is a potential new prognostic biomarker for patients with lung cancer.

He Y, Gong R, Peng KW, Liu LZ, Sun LY, Wang HY. He Y, et al. Biomark Med. 2020 Jun;14(9):717-726. doi: 10.2217/bmm-2019-0452. Epub 2020 Jul 9. Biomark Med. 2020. PMID: 32643402

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40,940 results

Search Page

Filters